Patents by Inventor Richard Tonai

Richard Tonai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220175674
    Abstract: This invention relates to processes and products for packaging and shipping therapeutic cells for cell therapy.
    Type: Application
    Filed: May 12, 2020
    Publication date: June 9, 2022
    Applicants: Stemcyte Inc., Rutgers, The State University of New Jersey
    Inventors: Monica Chen, Richard Tonai, Wise Young, Dongming Sun, Jonas Wang
  • Patent number: 6670124
    Abstract: A method for determining an HLA genotype of a subject is disclosed. The method comprises (a) isolating template nucleic acid from the subject; (b) amplifying the template nucleic acid to generate sufficient product for each allele of at least one gene locus to be determined; (c) hybridizing the template nucleic acid with an immobilized array of capture oligonucleotides, each having a known nucleic acid sequence of an HLA allele; and (d) determining the particular capture oligonucleotide to which the template nucleic acid hybridizes, thereby determining the genotype of the subject. A number of additional methods that can eliminate or abbreviate additional steps are also described. Moreover, the present invention provides a method for determining tissue compatibility using the determined HLA genotype.
    Type: Grant
    Filed: December 20, 2000
    Date of Patent: December 30, 2003
    Assignee: StemCyte, Inc.
    Inventors: Robert Chow, Richard Tonai
  • Publication number: 20030165884
    Abstract: A method for determining an HLA genotype of a subject is disclosed. The method comprises (a) isolating template nucleic acid from the subject; (b) amplifying the template nucleic acid to generate sufficient product for each allele of at least one gene locus to be determined; (c) hybridizing the template nucleic acid with an immobilized array of capture oligonucleotides, each having a known nucleic acid sequence of an HLA allele; and (d) determining the particular capture oligonucleotide to which the template nucleic acid hybridizes, thereby determining the genotype of the subject. A number of additional methods that can eliminate or abbreviate additional steps are also described. Moreover, the present invention provides a method for determining tissue compatibility using the determined HLA genotype.
    Type: Application
    Filed: April 25, 2002
    Publication date: September 4, 2003
    Applicant: StemCyte, Inc.
    Inventors: Robert Chow, Richard Tonai